Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug;28(4):355-362.
doi: 10.1007/s10286-018-0529-8. Epub 2018 May 15.

Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH)

Alessandra Fanciulli  1 , Jens Jordan  2 , Italo Biaggioni  3 , Giovanna Calandra-Buonaura  4   5 , William P Cheshire  6 , Pietro Cortelli  4   5 , Sabine Eschlboeck  1 , Guido Grassi  7   8 , Max J Hilz  9   10 , Horacio Kaufmann  11 , Heinz Lahrmann  12 , Giuseppe Mancia  13 , Gert Mayer  14 , Lucy Norcliffe-Kaufmann  11 , Anne Pavy-Le Traon  15   16 , Satish R Raj  17 , David Robertson  3 , Isabel Rocha  18 , Walter Struhal  19 , Roland Thijs  20   21 , Konstantinos P Tsioufis  22 , J Gert van Dijk  21 , Gregor K Wenning  23
Affiliations
Review

Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH)

Alessandra Fanciulli et al. Clin Auton Res. 2018 Aug.

Abstract

Purpose: Patients suffering from cardiovascular autonomic failure often develop neurogenic supine hypertension (nSH), i.e., high blood pressure (BP) in the supine position, which falls in the upright position owing to impaired autonomic regulation. A committee was formed to reach consensus among experts on the definition and diagnosis of nSH in the context of cardiovascular autonomic failure.

Methods: As a first and preparatory step, a systematic search of PubMed-indexed literature on nSH up to January 2017 was performed. Available evidence derived from this search was discussed in a consensus expert round table meeting in Innsbruck on February 16, 2017. Statements originating from this meeting were further discussed by representatives of the American Autonomic Society and the European Federation of Autonomic Societies and are summarized in the document presented here. The final version received the endorsement of the European Academy of Neurology and the European Society of Hypertension.

Results: In patients with neurogenic orthostatic hypotension, nSH is defined as systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg, measured after at least 5 min of rest in the supine position. Three severity degrees are recommended: mild, moderate and severe. nSH may also be present during nocturnal sleep, with reduced-dipping, non-dipping or rising nocturnal BP profiles with respect to mean daytime BP values. Home BP monitoring and 24-h-ambulatory BP monitoring provide relevant information for a customized clinical management.

Conclusions: The establishment of expert-based criteria to define nSH should standardize diagnosis and allow a better understanding of its epidemiology, prognosis and, ultimately, treatment.

Keywords: ABPM; Autonomic failure; Neurogenic orthostatic hypotension; Neurogenic supine hypertension; Nocturnal hypertension.

PubMed Disclaimer

Conflict of interest statement

Alessandra Fanciulli: nothing to declare. Jens Jordan: served as advisor for Janssen-Cilag, Novartis, Novo-Nordisk and Theravance and received research support from Boston Scientific outside of the submitted work; he is also co-founder of Eternygen GmbH. Italo Biaggioni: receives support from the NIH Rare Disease Clinical Research Network (U54-NS065736), reports consultancies for Lundbeck and Theravance for development of drugs to treat orthostatic hypotension and owns a patent application for an automated inflatable binder for the treatment of orthostatic hypotension. Giovanna Calandra–Buonaura: nothing to declare. William P. Cheshire: nothing to declare. Pietro Cortelli: nothing to declare. Sabine Eschlboeck: nothing to declare. Guido Grassi: nothing to declare. Max J. Hilz: nothing to declare. Horacio Kaufmann: receives support from the NIH Rare Disease Clinical Research Network (U54-NS065736). Heinz Lahrmann: nothing to declare. Giuseppe Mancia: nothing to declare. Gert Mayer: nothing to declare. Lucy Norcliffe–Kaufmann: receives support from the NIH Rare Disease Clinical Research Network (U54-NS065736). Anne Pavy-Le Traon: nothing to declare. Satish R. Raj: receives research support from the Canadian Institutes of Health Research (CIHR; Ottawa, ON, Canada) grant MOP142426 and the Cardiac Arrhythmia Network of Canada (CANet; London, ON, Canada) grants SRG-15-P01-001 and SRG-17-P27-001, and the Vanderbilt Institute for Clinical and Translational Research funded by a Clinical and Translational Science Award from the National Center for Advancing Translational Science from the National Institutes of Health (UL1 TR000445); he also reports consultancies for Lundbeck LLC and GE Healthcare. David Robertson: nothing to declare. Isabel Rocha: nothing to declare. Walter Struhal: nothing to declare. Roland Thijs: receives research support from the Dutch National Epilepsy Fund, ZonMW, NUTS Ohra Fund, Medtronic and AC Thomson Foundation, and has received fees for lectures from Medtronic, UCB and GSK. Konstantinos P. Tsioufis: nothing to declare. J. Gert Van Dijk: nothing to declare. Gregor K. Wenning: nothing to declare.

Figures

Fig. 1
Fig. 1
Nocturnal blood pressure (BP) profiles at 24 h-ambulatory BP monitoring a Physiological nocturnal dipping profile (mean nocturnal BP falls by ≥ 10% with respect to  daytime BP), b reduced-dipping profile (mean nocturnal BP falls by < 10% with respect to daytime BP), c rising profile (mean nocturnal BP increases with respect to daytime BP), in a patient with cardiovascular autonomic failure. Note severe hypotension occurring in the early morning. HR Heart rate. The blue area indicates the pulse pressure, the green line indicates the mean BP. Adapted from Fanciulli et al. [44], with permission of Springer SBM. This image is excluded from the creative commons license
See this image and copyright information in PMC

References

    1. Benarroch EE. The clinical approach to autonomic failure in neurological disorders. Nat Rev Neurol. 2014;10(7):396–407. doi: 10.1038/nrneurol.2014.88. - DOI - PubMed
    1. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72. doi: 10.1007/s10286-011-0119-5. - DOI - PubMed
    1. Fanciulli A, Gobel G, Ndayisaba JP, et al. Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res. 2016;26(2):97–105. doi: 10.1007/s10286-015-0336-4. - DOI - PubMed
    1. Cicolini G, Pizzi C, Palma E, et al. Differences in blood pressure by body position (supine, Fowler’s, and sitting) in hypertensive subjects. Am J Hypertens. 2011;24(10):1073–1079. doi: 10.1038/ajh.2011.106. - DOI - PubMed
    1. Krzesinski P, Stanczyk A, Gielerak G, Piotrowicz K, Banak M, Wojcik A. The diagnostic value of supine blood pressure in hypertension. Arch Med Sci. 2016;12(2):310–318. doi: 10.5114/aoms.2016.59256. - DOI - PMC - PubMed